CY2483B1 - Substituted bisindolylmaleimides for the inhibition of cell proliferation. - Google Patents

Substituted bisindolylmaleimides for the inhibition of cell proliferation.

Info

Publication number
CY2483B1
CY2483B1 CY0400081A CY0400081A CY2483B1 CY 2483 B1 CY2483 B1 CY 2483B1 CY 0400081 A CY0400081 A CY 0400081A CY 0400081 A CY0400081 A CY 0400081A CY 2483 B1 CY2483 B1 CY 2483B1
Authority
CY
Cyprus
Prior art keywords
inhibition
cell proliferation
bisindolylmaleimides
substituted
substituted bisindolylmaleimides
Prior art date
Application number
CY0400081A
Other languages
English (en)
Inventor
Donna Mary Huryn
Dennis Dalton Keith
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CY2483B1 publication Critical patent/CY2483B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CY0400081A 1996-07-29 2004-11-15 Substituted bisindolylmaleimides for the inhibition of cell proliferation. CY2483B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2207996P 1996-07-29 1996-07-29

Publications (1)

Publication Number Publication Date
CY2483B1 true CY2483B1 (en) 2005-06-03

Family

ID=21807711

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0400081A CY2483B1 (en) 1996-07-29 2004-11-15 Substituted bisindolylmaleimides for the inhibition of cell proliferation.

Country Status (23)

Country Link
US (2) US5856517A (cs)
EP (1) EP0915872B1 (cs)
JP (1) JP2000516589A (cs)
KR (1) KR20000029637A (cs)
CN (2) CN1495182A (cs)
AR (1) AR008267A1 (cs)
AT (1) ATE240318T1 (cs)
AU (1) AU739742B2 (cs)
BR (1) BR9711605A (cs)
CA (1) CA2262092A1 (cs)
CO (1) CO4900055A1 (cs)
CY (1) CY2483B1 (cs)
DE (1) DE69722003T2 (cs)
DK (1) DK0915872T3 (cs)
ES (1) ES2198001T3 (cs)
HR (1) HRP970414A2 (cs)
MA (1) MA24287A1 (cs)
PE (1) PE91698A1 (cs)
PT (1) PT915872E (cs)
SA (1) SA97180473A (cs)
TR (1) TR199900157T2 (cs)
WO (1) WO1998004552A1 (cs)
ZA (1) ZA976492B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1127500C (zh) * 1998-03-17 2003-11-12 弗·哈夫曼-拉罗切有限公司 抑制细胞增殖的取代双吲哚基马来酰亚胺
ES2220585T3 (es) * 1999-12-16 2004-12-16 Eli Lilly And Company Agentes y procedimiento para el tratamiento de enfermedades proliferativas.
US6743785B2 (en) * 1999-12-16 2004-06-01 Eli Lilly And Company Agents and methods for the treatment of proliferative diseases
US6313143B1 (en) * 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
WO2001044247A2 (en) * 1999-12-16 2001-06-21 Eli Lilly And Company Agents and methods for the treatment of proliferative diseases
US6281356B1 (en) 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
TWI335221B (en) 2001-09-27 2011-01-01 Alcon Inc Inhibtors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
US20030139373A1 (en) * 2001-11-20 2003-07-24 Breimer Lars Holger Method for cancer therapy
MY142390A (en) * 2002-05-22 2010-11-30 Glaxosmithkline Llc 3' - [(2z)-[1-(3,4-dimethylphenyl)-1,5- dihydro-3- methyl-5-0xo-4h-pyrazol-4- ylidene]hydrazino]-2' -hydroxy -[1,1' -biphenyl]-3-carboxylic acid bis-(monoethanolamine)
US7012100B1 (en) 2002-06-04 2006-03-14 Avolix Pharmaceuticals, Inc. Cell migration inhibiting compositions and methods and compositions for treating cancer
CN101133055B (zh) 2005-02-09 2011-05-25 艾科优公司 用于治疗癌症的meleimide衍生物、药物组合物以及方法
MX2009006533A (es) * 2006-12-19 2009-06-26 Novartis Ag Derivados de indolil-maleimida como inhibidores de cinasa.
CN101801969B (zh) 2007-06-22 2014-10-29 艾科尔公司 治疗癌症的吲哚基吡咯烷
JP5425060B2 (ja) 2007-06-22 2014-02-26 アークル インコーポレイテッド ピロリジノン、ピロリジン−2,5−ジオン、ピロリジンおよびチオスクシンイミド誘導体、癌の治療のための組成物および方法
MX2009013815A (es) 2007-06-22 2010-03-01 Arqule Inc Compuestos de quinazolinona y metodos de uso para los mismos.
JP2009035537A (ja) * 2007-07-10 2009-02-19 Nippon Synthetic Chem Ind Co Ltd:The N−置換アニリン誘導体及び1−置換インドール誘導体の製造方法
FR2927075A1 (fr) * 2008-02-04 2009-08-07 Centre Nat Rech Scient Molecules comprenant un squelette bis-(heteroaryl)maleimide, et leur utilisation dans l'inhibition d'enzymes
GB201111427D0 (en) * 2011-07-05 2011-08-17 Amakem Nv Novel bisindolylmaleimides, pan-pkc inhibitors
EP3104706B1 (en) 2014-02-11 2022-03-23 Mitokinin, Inc. Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
EP3169337A1 (en) 2014-07-17 2017-05-24 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for treating neuromuscular junction-related diseases
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections
EP3641545A4 (en) 2017-06-21 2021-02-24 Mitokinin, Inc. COMPOSITIONS AND METHODS USING THEM FOR THE TREATMENT OF NEURODEGENERATIVE AND MITOCHONDRIAL DISEASE

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89167A (en) * 1988-02-10 1994-02-27 Hoffmann La Roche Substituted pyrroles, their manufacture and pharmaceutical compositions containing them
PT93947B (pt) * 1989-05-05 1996-11-29 Goedecke Ag Processo para a preparacao de novos derivados de maleinimidas e de composicoes farmaceuticas que os contem
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
DE4005969A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte pyrrole, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
JPH0539289A (ja) * 1991-02-15 1993-02-19 Masahiro Irie 無水マレイン酸誘導体およびその製造方法
JPH07504673A (ja) * 1992-03-20 1995-05-25 ザ・ウエルカム・ファウンデーション・リミテッド 抗ウイルス活性を有するインドール誘導体
DE4217964A1 (de) * 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung

Also Published As

Publication number Publication date
EP0915872B1 (en) 2003-05-14
TR199900157T2 (xx) 1999-04-21
CN1495182A (zh) 2004-05-12
SA97180473A (ar) 2005-12-03
AR008267A1 (es) 1999-12-29
JP2000516589A (ja) 2000-12-12
AU3769097A (en) 1998-02-20
US5856517A (en) 1999-01-05
ATE240318T1 (de) 2003-05-15
US6030994A (en) 2000-02-29
HRP970414A2 (en) 1998-06-30
ZA976492B (en) 1998-01-29
PE91698A1 (es) 1998-12-24
DE69722003T2 (de) 2004-04-01
CO4900055A1 (es) 2000-03-27
CA2262092A1 (en) 1998-02-05
DE69722003D1 (de) 2003-06-18
AU739742B2 (en) 2001-10-18
KR20000029637A (ko) 2000-05-25
ES2198001T3 (es) 2004-01-16
EP0915872A1 (en) 1999-05-19
DK0915872T3 (da) 2003-09-08
BR9711605A (pt) 1999-08-24
WO1998004552A1 (en) 1998-02-05
PT915872E (pt) 2003-09-30
CN1151149C (zh) 2004-05-26
CN1226247A (zh) 1999-08-18
MA24287A1 (fr) 1998-04-01

Similar Documents

Publication Publication Date Title
ZA972000B (en) Inhibition of proliferation of cells.
CY2483B1 (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation.
ZA97912B (en) Heterocyclic compounds.
ZA9711092B (en) Novel compounds.
IL127563A0 (en) Cell adhesion inhibiting compounds
PL331338A1 (en) Thiosulphonamidic metaloprotease inhibitors
AU4296397A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
IL138247A0 (en) Substituted bisindolymaleimides for the inhibition of cell proliferation
ZA9711567B (en) Compounds.
AU129071S (en) Target
ZA979617B (en) Novel heterocyclic compounds.
ZA974953B (en) Substituted pyrazolylpyrazole derivatives.
ZA975861B (en) Bromotiacumicin compounds.
BR9710902A (pt) Bisindolilmaleimidas substituidas para a inibi-Æo de prolifera-Æo de celulas
ZA97928B (en) Novel heteroaryl-oxazolidinones.
AU4700197A (en) Corrosion inhibition
ZA979404B (en) Aspirinate compounds.
GB9617435D0 (en) Coating for thermoelasticity
IL150128A0 (en) Substituted bisindolymaleimides for the inhibition of cell proliferation
SI1064279T1 (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
HUP9700601A3 (en) Gasholder
GB9603545D0 (en) The spraymate
ZA974411B (en) Prepayment of royalties.
AU2086597A (en) Inhibition of proliferation of cells
ZA979045B (en) Derivates of pentaerythrits.